Nixon J Scott 4

What Happened

• Nixon J. Scott, a director of USANA Health Sciences, was granted 6,527 restricted stock units (RSUs) on May 7, 2026. The grant is reported as an award (Form 4 code A) with an acquisition price of $0.00 — no cash exchanged at grant. These RSUs are derivative awards that convert to common shares only upon vesting.

Key Details

• Transaction date: 2026-05-07; filing date: 2026-05-11 (filed within the SEC’s 2 business-day window).
• Award: 6,527 restricted stock units (RSUs); reported acquisition price: $0.00.
• Vesting (per filing footnote): 25% vests on each of Jul 23, 2026; Oct 22, 2026; Jan 21, 2027; and Apr 22, 2027.
• Footnote: Each RSU represents a contingent right to receive one share of USANA common stock upon vesting.
• Shares owned after the transaction: Not specified in the information provided.
• Transaction code: A = Award/Grant; this is a derivative grant (not a market purchase or sale).

Context

• RSU grants are common for director compensation; they do not represent immediate transferable share ownership and will only become actual shares as they vest. Such awards are routinely reported and, by themselves, do not necessarily indicate the director’s trading sentiment.